A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive.Laila I. Muderspach, Jeffrey S. Weber, Lynda D. Roman et al.|PubMed|2000Cited by 311